107,286 Shares in Neogen Co. (NASDAQ:NEOG) Bought by Brown Advisory Inc.

Brown Advisory Inc. purchased a new position in Neogen Co. (NASDAQ:NEOGFree Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 107,286 shares of the company’s stock, valued at approximately $1,987,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in NEOG. Bell Bank purchased a new stake in shares of Neogen during the first quarter worth $215,000. Premier Fund Managers Ltd purchased a new stake in shares of Neogen during the first quarter worth $510,000. Lindbrook Capital LLC purchased a new stake in shares of Neogen during the first quarter worth $29,000. Clean Yield Group purchased a new stake in shares of Neogen during the first quarter worth $149,000. Finally, Wrapmanager Inc. purchased a new stake in shares of Neogen during the first quarter worth $578,000. Hedge funds and other institutional investors own 93.35% of the company’s stock.

Neogen Trading Up 4.9 %

Shares of NEOG stock opened at $23.61 on Tuesday. The company’s 50-day moving average price is $21.66 and its 200-day moving average price is $19.35. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.03 and a quick ratio of 3.11. Neogen Co. has a twelve month low of $10.49 and a twelve month high of $23.80.

Neogen (NASDAQ:NEOGGet Free Report) last announced its quarterly earnings results on Thursday, July 27th. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.11. The firm had revenue of $241.80 million for the quarter, compared to analysts’ expectations of $227.72 million. Neogen had a negative net margin of 2.78% and a positive return on equity of 4.06%. The company’s revenue was up 71.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.18 EPS. As a group, equities analysts expect that Neogen Co. will post 0.58 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on NEOG. Piper Sandler upped their target price on shares of Neogen from $19.00 to $24.00 in a report on Monday, August 7th. StockNews.com began coverage on shares of Neogen in a report on Thursday, May 18th. They set a “sell” rating for the company. Finally, Wells Fargo & Company upped their target price on shares of Neogen from $22.00 to $28.00 and gave the stock an “overweight” rating in a report on Monday.

Get Our Latest Report on NEOG

About Neogen

(Free Report)

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells.

Featured Articles

Institutional Ownership by Quarter for Neogen (NASDAQ:NEOG)

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.